Cite
HARVARD Citation
Dearden, L. et al. (2019). Fatigue, treatment satisfaction and health‐related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate‐resistant prostate cancer. European journal of cancer care. p. n/a. [Online].